Ali Behbahani - 21 Mar 2025 Form 4 Insider Report for Black Diamond Therapeutics, Inc. (BDTX)

Quoteable Key Fact

"Ali Behbahani filed Form 4 for Black Diamond Therapeutics, Inc. (BDTX) on 21 Mar 2025."

Quick Takeaways

This page summarizes Ali Behbahani's Form 4 filing for Black Diamond Therapeutics, Inc. (BDTX).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 21 Mar 2025, 16:19.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDTX	Common Stock	Award	$14,374	+7,646	+12%	$1.88	70,980	21 Mar 2025	Direct	F1, F2
holding	BDTX	Common Stock						4,448,757	21 Mar 2025	See Note 3	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
F2	The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 20, 2025.
F3	The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.